Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Embody and Medivive for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Embody offers both semaglutide and tirzepatide at $69/month with a rating of 7.2/10. Medivive also provides both semaglutide and tirzepatide at $162/month with a 7.4/10 rating.
The price difference of $93/month is significant - Embody is the more budget-friendly option, while Medivive positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Embody | Medivive |
|---|---|---|
| Monthly Price | $69 | $162 |
| Rating | 7.2/10 | 7.4/10 |
| Medications | semaglutide, tirzepatide | semaglutide, tirzepatide |
| Insurance Accepted | No | No |
| Support Hours | Not published | Not published |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | 1-2 day delivery claimed | Delivered to your door; refills arrive on schedule |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Ongoing support; frequency not published | Provider adjusts treatment over time as labs change; no fixed schedule published |
| Money-back Guarantee | Refund only if a provider disqualifies you, or before your medication is ordered; consultation fees are never refundable | Nothing to pay until a provider reviews your case |
| Cancellation Policy | Cancel anytime, but the policies state two different deadlines - 72 hours before billing, or 5 days before the end of your prescription period | Billed monthly; cancellation terms not published |

